K PharmaTSE:4896 +5.46%11 OCF Yield % is -11.22 as of Jul. 04, 2026. GuruFocus rates TSE:4896 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 1,414 Biotechnology companies, K Pharma ranks worse than 56.58% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
K Pharma OCF Yield % Related Terms
K Pharma OCF Yield % Historical Data
* Premium members only.
The historical data trend for K Pharma's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4896 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, K Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
K Pharma OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, K Pharma's OCF Yield % distribution charts can be found below:
* The bar in red indicates where K Pharma's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
K Pharma (TSE:4896) has a OCF Yield % of -11.22 as of Jul. 04, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on K Pharma and its competitors. According to the industry distribution chart, K Pharma ranks #800 out of 1414 companies in the Biotechnology industry, placing it in the top 56.6%.
Is K Pharma's OCF Yield % too high?
K Pharma's current OCF Yield % is -11.22. Based on the distribution chart, K Pharma ranks #800 out of 1414 companies in the Biotechnology industry, which is below the industry midpoint. Overall, K Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, K Pharma ranks #800 out of 1414 companies for OCF Yield %. This places K Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on K Pharma and its competitors. K Pharma's current OCF Yield % is -11.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current OCF Yield % of -11.22. The current OCF Yield % is -11.22. K Pharma's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For K Pharma (TSE:4896), the current OCF Yield % is -11.22 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score
Get the complete analysis for TSE:4896
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4896 has been successfully added to your 
